Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Asel Biktasova"'
Autor:
Wendell G. Yarbrough, Natalia Issaeva, Darren R. Tyson, Yiling Lu, Gordon B. Mills, Asel Biktasova, Brandee Brown, Andrew Sewell
PDF file - 200KB, Immunoblotting of HPV(+) SCC090 cells stably transfected with either wild type or E545K mutant PIK3CA vectors with pS6, pS6K and pAKT antibodies. Actin antibody was used as a loading control.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe38674221f231c78bc04c92b60e5e2
https://doi.org/10.1158/1078-0432.22448250.v1
https://doi.org/10.1158/1078-0432.22448250.v1
Autor:
Natalia Issaeva, Wendell G. Yarbrough, Saral Mehra, Benjamin Judson, Barbara Burtness, Aarti Bhatia, Hari A. Deshpande, Gary Bellinger, Cyril Gary, Andrew Sewell, Michael Hajek, Asel Biktasova
qRT-PCR primers used in the study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14012939492768d95b03783a41e7d24e
https://doi.org/10.1158/1078-0432.22466993.v1
https://doi.org/10.1158/1078-0432.22466993.v1
Autor:
Natalia Issaeva, Wendell G. Yarbrough, Saral Mehra, Benjamin Judson, Barbara Burtness, Aarti Bhatia, Hari A. Deshpande, Gary Bellinger, Cyril Gary, Andrew Sewell, Michael Hajek, Asel Biktasova
A. % line-1 methylation after 5-aza treatment in HPV+ (1-5) and HPV- tumors from the window clinical trial. B. % Line-1 methylation in HPV+ UMSCC47 cells before and after 5-aza treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00c77981e7774c35e9934fbba4a83fa1
https://doi.org/10.1158/1078-0432.22467002
https://doi.org/10.1158/1078-0432.22467002
Autor:
Wendell G. Yarbrough, Natalia Issaeva, Darren R. Tyson, Yiling Lu, Gordon B. Mills, Asel Biktasova, Brandee Brown, Andrew Sewell
PDF file - 37KB, Differentially expressed proteins in HPV(+) vs HPV(-) OPSCC (0.05
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21af89e338b53d6ab47b5729e608bb5c
https://doi.org/10.1158/1078-0432.22448244
https://doi.org/10.1158/1078-0432.22448244
Autor:
Eduardo Méndez, Christopher J. Kemp, Carla Grandori, Adam A. Margolin, Wendell G. Yarbrough, Asel Biktasova, In Sock Jang, Kay E. Gurley, Christopher M. Schaupp, Luisa Angelica Lerma, James Annis, Michael Kao, Chang Xu, Russell Moser
Figure S4. Body weight of MK-1775 treated mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c1211c377dbd3da8c36d2a805d42bd6
https://doi.org/10.1158/1078-0432.22447263.v1
https://doi.org/10.1158/1078-0432.22447263.v1
Autor:
Eduardo Méndez, Christopher J. Kemp, Carla Grandori, Adam A. Margolin, Wendell G. Yarbrough, Asel Biktasova, In Sock Jang, Kay E. Gurley, Christopher M. Schaupp, Luisa Angelica Lerma, James Annis, Michael Kao, Chang Xu, Russell Moser
Tables S18-20: Table S18. Secondary validation assay statistical analysis (absolute viability) Table S19. Differential viability and caspase 3/7 dependent apoptosis AUC of secondary validation assay Table S20. Statistical analysis summary differentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89728d414cc39df0ebbae89c2701037d
https://doi.org/10.1158/1078-0432.22447248
https://doi.org/10.1158/1078-0432.22447248
Autor:
Natalia Issaeva, Wendell G. Yarbrough, Saral Mehra, Benjamin Judson, Barbara Burtness, Aarti Bhatia, Hari A. Deshpande, Gary Bellinger, Cyril Gary, Andrew Sewell, Michael Hajek, Asel Biktasova
Fold change in MMPs 1 and 10 expression in HPV+ primary culture after 5-aza treatment, as determined by qRT-PCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0bc59cb63047ffc6133a4d95a7af36
https://doi.org/10.1158/1078-0432.22467008
https://doi.org/10.1158/1078-0432.22467008
Autor:
Wendell G. Yarbrough, Natalia Issaeva, Darren R. Tyson, Yiling Lu, Gordon B. Mills, Asel Biktasova, Brandee Brown, Andrew Sewell
PDF file - 157KB, UMSCC-47 parental and stably overexpressing mutant or wild-type PI3KCA cells were treated with increasing concentrations of AKT (MK-2206) or dual PI3KCA/mTOR (BEZ-235) inhibitor, and cells survival was assessed after 7 days of treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2dc53d5bd0152399b29a3ab28a38bf0
https://doi.org/10.1158/1078-0432.22448247.v1
https://doi.org/10.1158/1078-0432.22448247.v1
Autor:
Eduardo Méndez, Christopher J. Kemp, Carla Grandori, Adam A. Margolin, Wendell G. Yarbrough, Asel Biktasova, In Sock Jang, Kay E. Gurley, Christopher M. Schaupp, Luisa Angelica Lerma, James Annis, Michael Kao, Chang Xu, Russell Moser
Purpose: To identify novel therapeutic drug targets for p53-mutant head and neck squamous cell carcinoma (HNSCC).Experimental Design: RNAi kinome viability screens were performed on HNSCC cells, including autologous pairs from primary tumor and recur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5715f9df69076ca82341e78f832fdb48
https://doi.org/10.1158/1078-0432.c.6521022
https://doi.org/10.1158/1078-0432.c.6521022
Autor:
Natalia Issaeva, Wendell G. Yarbrough, Saral Mehra, Benjamin Judson, Barbara Burtness, Aarti Bhatia, Hari A. Deshpande, Gary Bellinger, Cyril Gary, Andrew Sewell, Michael Hajek, Asel Biktasova
Fold change in the expression of HPV genes in SCC090 cells after 5-aza treatment, as determined by qRT-PCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76a399e74867a3429d4cd423c08cb09e
https://doi.org/10.1158/1078-0432.22467011.v1
https://doi.org/10.1158/1078-0432.22467011.v1